Trials / Completed
CompletedNCT02462499
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Semmelweis University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine the efficacy and safety of treatment with the drug eplerenone in patients with chronic central serous chorioretinopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inspra (eplerenone) |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2015-06-04
- Last updated
- 2016-10-18
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT02462499. Inclusion in this directory is not an endorsement.